Cargando…
Osteometabolic profile and bone mass in the transition phase: ethnic differences in Brazilians treated with somatropin during childhood
OBJECTIVE: The main growth hormone action is to promote linear growth increasing protein synthesis stimulation and osteoblastic activity. Peak bone mass extends from adolescence to 30 years of age. Several factors may influence this acquisition and prevent fracture risk in adulthood, such as genetic...
Autores principales: | Kuba, Valesca M., Castro, Antonia B.S., Leone, Cláudio, Damiani, Durval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031360/ https://www.ncbi.nlm.nih.gov/pubmed/36155741 http://dx.doi.org/10.1016/j.jped.2022.08.001 |
Ejemplares similares
-
Is waist-to-height ratio a useful indicator of cardio-metabolic risk in 6-10-year-old children?
por: Kuba, Valesca Mansur, et al.
Publicado: (2013) -
Osteometabolism: Metabolic Alterations in Bone Pathologies
por: Srivastava, Rupesh K., et al.
Publicado: (2022) -
Somatropin therapy in italian adults with growth hormone deficiency
por: Pricci, Flavia, et al.
Publicado: (2022) -
Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis – A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso)
por: Madeira, Miguel, et al.
Publicado: (2020) -
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
por: Frindik, J Paul, et al.
Publicado: (2010)